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ABSTRACT
Muscle differentiation and expression of muscle-
specific proteins are initiated by the binding of
heterodimers of the transcription factor MyoD with
E2A proteins to E-box motif d(CANNTG) in promo-
ters or enhancers of muscle-specific genes. MyoD
homodimers, however, form tighter complexes with
tetraplex structures of guanine-rich regulatory
sequences of some muscle genes. In this work,
we identified elements in MyoD that bind E-box or
tetraplex structures of promoter sequences of the
muscle-specific genes a7 integrin and sarcomeric
Mitochondrial Creatine Kinase (sMtCK). Deletions
of large domains of the 315 amino acids long
recombinant MyoD indicated that the binding site
for both E-box and tetraplex DNA is its basic region
KRKTTNADRRKAATMRERRR that encompasses
the three underlined clusters of basic residues
designated R1,R 2 and R3. Deletion of a single or
pairs of R triads or R111C substitution completely
abolished the E-box-binding capacity of MyoD.
By contrast, the MyoD deletion mutants "102–114,
"R3, "R1R3 or "R2R3 maintained comparable tetra-
plex DNA-binding capacity as reflected by the
similar dissociation constants of their protein–DNA
complexes. Only deletion of all three basic clusters
abolished the binding of tetraplex DNA. Implications
of the binding of E-box and tetraplex DNA by
non-identical MyoD elements are considered.
INTRODUCTION
Gene transcription is tightly regulated at multiple
levels. Two expansively investigated mechanisms are the
epigenetic modiﬁcation by methylation of gene regulatory
sequences and the remodeling of chromatin by enzymatic
modiﬁcations of histones and disruption of histone–
DNA interactions. Structural transitions from B-DNA
to non-B-DNA that are generated by positive or negative
superhelical stress in DNA constitute a third level of
transcription regulation (1,2). Of the non-B-DNA struc-
tures, tetraplex or G-quadruplex conﬁgurations of
guanine-rich sequences are of special interest. Evidence
showed that the expression of multiple genes such as
chicken b-globin, mouse MCK and a7 integrin and human
insulin, c-myc, sMtCK and FMR1 was aﬀected by
tetraplex structures that were formed in their promoter
or enhancer regions or that the tetrahelical DNA served as
target for transcription factors (3). We reported recently
that segments of promoter and enhancer regions of several
muscle-speciﬁc genes had a disproportional high preva-
lence of clusters of contiguous guanine residues and that
these sequences readily folded in vitro into hairpin and
parallel-stranded G04 unimolecular and G02 bimolecular
tetraplex structures (4). We also found that homodimers
of the myogenic master transcription factor MyoD bound
preferentially to these tetrahelical structures (5). Based on
these observations, we proposed that tetraplex domains in
regulatory regions of muscle-speciﬁc genes may contribute
to their expression during embryonic diﬀerentiation.
Skeletal muscle tissue diﬀerentiates from embryonic
omnipotent mesodermal stem cells in a series of successive
steps. Cells that commit to myogenic precursors initially
divide as myoblasts that in turn cease to proliferate and
initiate the expression of muscle-speciﬁc genes. In a ﬁnal
step, the cells fuse to form fully diﬀerentiated syncitial
myotubes (6–8). Coordinated activation of the various
muscle-speciﬁc genes during myogenesis is regulated by
four myogenic MRF transcription regulatory factors;
MyoD, Myf-5, MRF4 (Myf-6) and myogenin that
comprise a subgroup within the superfamily of basic
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vation of the various MRFs in mouse germ line showed
initially that MyoD and Myf-5 act as determination
factors that control the commitment of proliferating
somitic cells to the myogenic lineage (11–13), whereas
MRF4 and myogenin direct the subsequent diﬀerentiation
of committed myoblasts into myocytes and myotubes
(14–17). More recent data suggested, however, that
MRF4-like Myf5 also operates as a determination factors
upstream of MyoD by directing omnipotent embryonic
cells into the myogenic lineage (18). Being tissue-speciﬁc
(class II) bHLH proteins, the MRFs either self-associate
through their HLH segment to form homodimers or link
with class I bHLH proteins that include HEB/HTF4,
E2-2/ITF-2 and E2A proteins (E12 and E47) to form
heterodimers (10). Structure–function analysis of MRFs
revealed that their basic region serves as the DNA-binding
site (19). MyoD forms heterodimers with the bHLH
proteins E12, E47 and ITF1at greater eﬃciency than
its self-association into homodimers (19–21). Studies of
myogenesis in cell cultures showed that transcription
of muscle-speciﬁc genes is initiated by the binding of
MyoD-E12 or MyoD-E47 heterodimers to a conserved
E-box motif d(CANNTG) in promoters or enhancers of
the activated genes. Although homodimers of the 60
amino acids long bHLH domain of MyoD were also
reported to bind speciﬁcally to E-box DNA in vitro (20)
and to induce myogenesis in stably transfected mouse
ﬁbroblasts (22), homodimers of full-length MyoD
displayed signiﬁcantly lower aﬃnity for E-box than the
MyoD-E12 heterodimers (20,23).
In an earlier work it was reported that recombinant
MyoD bound tetrahelical structures of a guanine-rich
mouse creatine kinase enhancer sequence and of
Tetrahymena telomeric DNA (24). Measurement of the
dissociation constants of MyoD–DNA complexes
revealed that the association of MyoD with tetraplex
DNA was 4- to 5-fold tighter than with E-box DNA.
More recently we demonstrated that MyoD homodimers
bound tightly to bimolecular DNA tetraplexes of the
muscle gene DNA sequences but did not associate with
their single-stranded, hairpin, double-stranded or intra-
molecular tetraplex forms (5). Moreover, measurements
of dissociation constants, Kd, of protein–DNA complexes
revealed that MyoD homodimers formed signiﬁcantly
tighter complexes with the G02 DNA tetraplexes than with
E-box DNA. Conversely, MyoD-E47 heterodimers bound
E-box more tightly than G02 tetraplex DNA structures.
We proposed that the preferential binding of the rela-
tively inactive MyoD homodimers to tetraplex domains
in regulatory regions of muscle-speciﬁc genes may
prevent unproductive occupation of the E-box by MyoD
homodimers (5).
The diﬀerential binding of MyoD homo- and hetero-
dimers to E-box and to tetraplex DNA invited structure–
function analysis of the interaction of this protein with the
two DNA elements. We thus identiﬁed in this study
MyoD elements that participate in the binding of E-box
and tetraplex structures of promoter sequences of two
muscle-speciﬁc genes. We report that the basic region of
MyoD serves as the binding site for both DNA types.
However, whereas a point mutation or minimal deletions
in this region inactivate the capacity of MyoD to bind
E-box, tetraplex DNA can be bound by MyoD variant
proteins that possess just a single cluster of three basic
amino acids within their mutated basic region. The
contrasting stringent structural requirements of MyoD
for the binding of E-box as opposed to the minimal
demands for its association with tetraplex DNA may serve
in the binding of MyoD to alternate genomic targets prior
to the activation of muscle-speciﬁc genes during muscle
diﬀerentiation.
MATERIALS AND METHODS
Preparation of double-stranded E-box andbimolecular
tetraplex DNA structures
The synthetic DNA oligomers Integrin and sMtCK
(Table 1) whose nucleotide sequences were derived from
guanine-rich promoter regions of the genes sarcomeric
Mitochondrial Creatine Kinase and a7 integrin (4), respec-
tively, were puriﬁed by denaturing gel electrophoresis in
8.0M urea, 12% polyacrylamide (acryl/bisacrylamide,
19:1) (25), andwere subsequently 50-
32Plabeled in bacterio-
phage T4 polynucleotide kinase-catalyzed reaction.
Table 1. DNA oligomers used in this work
Oligomer Bases Nucleotide sequence
50-E-box 26 50-d[TCGATCCCCCAACACCTGCTGCCTGA]-30
30-E-box 26 50-d[TCAGGCAGCAGGTGTTGGGGGATCGA]-30
Integrin 26 50-d[CATGGGGGCGGGAAGGGGCGGGGTCT]-30
sMtCK 24 50-d[CTGAGGAGGGGCTGGAGGGACCAC]-30
50-119–121 31 50-d[GCCACCATGCGCGAGCTGAGCAAAGTGAATG]-30
30-119–121 31 50-d[CATTCACTTTGCTCAGCTCGCGCATGGTGGC]-30
50-102–104C 29 50-d[CTGCAAGGCGTGCACCACCAACGCTGATC]-30
30-102–104G 29 50-d[GATCAGCGTTGGTGGTGCACGCCTTGCAG]-30
50-110–112 25 50-d[GACCACCAACGCTGATGCCGCCACC]-30
30-110–112 25 50-d[GGTGGCGGCATCAGCGTTGGTGGTC]-30
50-102–104G 29 50-d[CTGCAAGGCGTGCACCACCAACGCTGATG]-30
30-102–104C 29 50-d[CATCAGCGTTGGTGGTGCACGCCTTGCAG]-30
Complementary E-box core sequences are underlined in the 50 and 30 E-box oligomers. Tetrad forming clusters of guanine residues are underlined in
the integrin and sMtCK oligomers that were, respectively, derived from guanine-rich promoter regions of the genes a7 integrin or sarcomeric
mitochondrial creatine kinase.
7088 Nucleic Acids Research, 2007, Vol. 35, No. 21Bimolecular quadruplex structures of the two oligomers
were formed as we described (4). A DNA double strand
that contained the E-box CACCTG–CAGGTG motif was
prepared by annealing equimolar amounts of the 50- and
30-E-box oligomers, (Table 1), as previously detailed (26).
Preparation, purification and expression offull-length
and mutantrecombinant MyoD
GST-fused full-length Mus musculus MyoD cDNA was
ligated into a pRK171a vector and cloned in Escherichia
coli XL-1. Plasmids harboring MyoD 102–114 mutant
DNA or its bHLH domain (residues 102–162)
(see Figure 1 for a map), were generously contributed by
Dr S. J. Tapscott (FHCRC, Seattle). Large regions of
MyoD DNA were deleted by PCR ampliﬁcation of a
desired fragment of the full-length cDNA using primers
that consisted of 50 or 30 sequences of the MyoD fragment
and pGEX-6P sequences, which had EcoRI and XhoI
restriction sites, respectively. An R111C point mutation
was generated in MyoD cDNA by PCR ampliﬁcation
using primers that contained an R to C substitution in
codon 111. The R3 cluster of the three amino acids RRR
was deleted from the MyoD basic region by PCR using
full-length MyoD cDNA template and 50 and 30 119–121
primers (Table 1). Doubly deleted R1R3 MyoD cDNA
was generated by PCR using R3 MyoD template DNA
and 50-102–104C and 30-102–104G primers (Table 1).
The R2R3 MyoD mutant was similarly prepared except
that the primers 50-110–112 and 30-110–112 were used.
A triple R1R2R3 MyoD mutant was generated by PCR
employing a R2R3 MyoD cDNA template and the
50-102–104G and 30-102–104C primers (Table 1).
Because of the high guanine–cytosine content of sequences
in the vicinity of the R1,R 2 and R3 clusters a specialized
PCR protocol devised by Ralser et al. (27) was employed
to produce the various deletion mutations. Brieﬂy,
reaction mixtures contained in a ﬁnal volume of 50ml:
10ng pGEX-6P full-length or mutant MyoD DNA
template; 2.5 units Pfu-Ultra DNA polymerase; 5ml1 0  
polymerase buﬀer; 20pmol each of 30 and 50 primers;
1mM dNTPs and 6.6ml of enhancer solution consisting of
83mg/ml BSA, 10mM DTT, 10% DMSO and 4M
Betaine. The ampliﬁcation program included 2min at
958C, followed by 30 cycles of DNA melting at 958C for
30s and elongation and annealing at 728C for 6min and
concluded with a single step of additional elongation at
728C for 10min. Following selection and isolation of
mutant clones and veriﬁcation of the desired mutation by
DNA sequencing, full-length and mutant MyoD proteins
were expressed in E. coli BL21(DE3)pLysS cells as we
described (5). The recombinant proteins were puriﬁed to
>95% homogeneity from the bacterial cell extracts by
glutathione-agarose (Sigma) aﬃnity column chromato-
graphy. The GST residue was cleaved by incubating
100mg of fusion protein for 4h and at 48C with 2.0U
preScission protease (Amersham Biosciences).
Electrophoretic mobility shift assayof proteinbinding
toDNA anddetermination of dissociation constants
ofthe protein–DNA complexes
Homodimers of full-length or mutant MyoD were formed
prior to their binding to DNA probes by incubating
speciﬁed amounts of puriﬁed recombinant protein for
10min at 378C in reaction mixtures that contained in a
ﬁnal volume of 10ml: 45mM KCl, 4.5mM MgCl2, 0.5mM
EDTA, 1mM DTT, 20% glycerol, 20mM Tris–HCl
buﬀer, pH 8.0, and 0.5mg HeLa whole cell extract.
Reaction mixtures for protein–DNA binding contained
in a ﬁnal volume of 10ml: speciﬁed amounts of full-length
or mutant MyoD homodimers and 50-
32P labeled DNA
probe, 14.5mM KCl, 0.45mM MgCl2, 0.5mM EDTA,
1mM DTT, 20% glycerol and 0.05mg HeLa whole cell
extract in 20mM Tris–HCl buﬀer, pH 8.0. Reaction
mixtures for the binding of 50-
32P labeled double-stranded
E-box DNA also contained 100-fold (w/w) excess of
unlabeled poly d(I-C) (Sigma). Mixtures for the binding of
end-labeled G02 bimolecular tetraplex DNA structures
of the integrin or sMtCK sequences contained 100-fold
(w/w) excess of unlabeled single-stranded oligomer of the
same sequence. The mixtures were incubated for 20min at
308C and protein–DNA complexes were resolved from
free DNA by electrophoresis at 48C and 200–250V in non-
denaturing 4% polyacrylamide gel (acryl/bisacrylamide,
19:1) in 10mM KCl, 0.25  TBE buﬀer (1.2mM EDTA in
0.54mM Tris–borate buﬀer, pH 8.3). Electrophoresis of
the DNA was conducted until a bromophenol blue marker
dye migrated 7.5cm into the gel. The gels were dried on
DE81 ﬁlter paper and the relative proportions of bands
of free and protein-bound DNA were quantiﬁed by
phosphor imaging analysis.
To determine dissociation constants, Kd, of complexes
of normal or mutant MyoD with E-box DNA or with
G02 tetraplex structures of integrin, increasing amounts of
32P-labeled DNA were incubated with a constant amount
of protein under the above described conditions.
Figure 1. Scheme of MyoD domains and deletion mutations in its basic
region. Deletion mutations were generated within the basic region,
(residues 102–121), as described under Materials and Methods section.
The triads of basic amino acids, R1,R 2 and R3 are boxed.
Nucleic Acids Research, 2007, Vol. 35, No. 21 7089Following electrophoretic mobility shift resolution of the
protein–DNA complexes from free DNA, their relative
amounts were determined by phosphor imaging quantiﬁ-
cation of the dried gel. Kd values were derived from the
negative reciprocal of the slope of a Scatchard plot of
the results as we detailed elsewhere (28).
RESULTS
The MyoD basic region isthe binding sitefor both
E-boxand tetraplex DNA
Homodimeric MyoD associates more tightly with tetra-
plex forms of regulatory sequences of muscle-speciﬁc
genes than with E-box DNA motif, which is the preferred
binding target for MyoD-E47 heterodimers (5,24). MyoD
domains include the N-terminal transcription activation
region, a cysteine–histidine C/H-rich domain, a basic
region which was shown to be the E-box-binding site (19),
a helix-loop-helix (HLH) domain that mediate oligo-
merization, and a C-terminal stretch (Figure 1, top).
To identify the region in MyoD to which tetraplex DNA
binds, we assessed the capacity of mutant MyoD proteins
that lacked deﬁned domains to associate with E-box and
G02 tetraplex integrin DNA. Data summarized in Table 2
indicated that the activation domain and the C/H region
were not required for the binding of E-box and G02
tetraplex DNA. However, extending the deletion to the
end of basic region abolished the binding of both types
of DNA. Conversely, isolated bHLH domain (residues
102–162) formed complexes with both E-box and G02
integrin DNA (Table 2). These results suggested that
similar to E-box, the binding of tetraplex DNA was also
mediated by the basic domain of MyoD.
MutatedMyoD basic region binds tetraplex DNA
butnot E-box
To inquire whether or not the E-box and tetraplex-binding
sites completely overlap, we compared the DNA-binding
capacity of a MyoD mutant that contained a 102–114
partial deletion within the 20 amino acids long basic
region that extends from residue 102–121 (Figure 1).
As shown in Figure 2A, the mutant protein failed to
detectably associate with E-box DNA whereas it bound
G02 integrin DNA to almost the same extent as full-length
MyoD (Figure 2B). The diﬀerent MyoD structure require-
ments for the binding of E-box and tetraplex DNA were
further underscored by a comparison of their ability to
associate with a MyoD R111C mutant protein. As shown
in the left panel of Figure 3, substituting the 111 residue in
the center of the basic region (Figure 1) from ariginine
to cysteine completely abolished the capacity of MyoD to
bind E-box DNA. By clear contrast, the R111C mutant
protein associated with G02 tetraplex integrin DNA to
practically the same extent as did native MyoD (Figure 3,
right panel). Put together, results shown in Table 2 and in
Figures 2 and 3 indicated that although the MyoD basic
region served as the common binding site for both E-box
and tetraplex DNA, binding of E-box required an intact
basic region whereas tetraplex DNA could associate with
a partially deleted or mutated basic region.
A singlecluster ofthree basic amino acids suffices
forthe binding oftetraplex DNA
Since mutated basic region of MyoD maintained its
capacity to bind tetraplex DNA, we undertook to deﬁne
the minimum requirements for the binding of tetrahelical
structures of integrin and sMtCK regulatory sequences.
A prominent feature of the basic region is that it includes
three clusters of three basic amino acids each. These
clusters, KRK at positions 102–104, RRK at 110–112 and
RRR at 119–121, were designated R1,R 2 and R3,
respectively (Figure 1). The capacity of 102–114 MyoD
protein to bind G02 integrin DNA, (Figure 2B) indicated
that a largely deleted basic region with only a short stretch
of 7 amino acids remaining at its C-terminus was capable
of binding the tetraplex structure. Since this remainder of
the basic region included the R3 cluster, we speculated that
any single cluster of three basic amino acids may be
necessary and suﬃcient for the binding of tetraplex DNA.
To test this hypothesis, we assessed the capacities of a
series of mutant MyoD proteins that lacked one, two or
three basic amino acids clusters to bind E-box and G02
tetraplex structures of integrin or sMtCK DNA.
Representative results of electrophoretic mobility shift
analysis shown in the ﬁrst panel of Figure 4A indicated
that whereas MyoD with an intact basic region formed a
complex with E-box DNA, deletion of the R3 cluster alone
or in combination with R1,R 2 or both resulted in a
complete loss of the E-box-binding capacity. By contrast,
full-length MyoD as well as its mutants R3, R1R3
and R2R3 formed complexes with G02 tetraplex struc-
tures of integrin or sMtCK DNA and only the triply
deleted mutant protein R1R2R3 lost the capacity to bind
the two tetrahelices (Figure 4A, second and third panels).
Notably, these data also showed that the deletion muta-
tion partially compromised the tetraplex DNA-binding
capacity of MyoD. This was conﬁrmed by following
the binding of a constant amount of G02 tetraplex forms
Table 2. The MyoD basic region is required for the binding of both
E-box and G02 tetraplex integrin DNA
Protein DNA binding
G02 integrin DNA E-box DNA
Full-length MyoD + +
Deleted activation
region (3–56)
++
Deleted activation and
C/H regions (1–93)
++
Deleted activation, C/H and
basic regions (1–121)
  
Isolated bHLH domain
(residues 102–162)
++
Increasing amounts of full-length or mutant MyoD proteins
(0–30pmol) were incubated with 65 fmol of 50-
32P labeled E-box or
G02 integrin DNA under binding conditions and protein–DNA
complexes were resolved from free DNA by non-denaturing 4%
polyacrylamide electrophoresis as described in the Materials and
Methods section. Marking of ( ) signiﬁes absence of detectable
protein–DNA complex at the highest amount of added protein.
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of full-length or mutant MyoD proteins. As shown in
Figure 4B, in this experiment, the binding of G02 integrin
DNA was only minimally diminished by deletion of the R3
cluster and removal of this triad of basic residues even
increased complex formation with G02 sMtCK. Combined
deletion of two clusters, R1 and R3 or R2 and R3, was
more detrimental, signiﬁcantly diminishing the protein-
binding capacity for G02 integrin binding and even more
so for G02 sMtCK DNA. Similar titration showed that
any added amount of the triple deletion mutant R1R2R3
failed to detectably bind either G02 integrin or sMtCK
DNA (data not shown).
The affinityof MyoD fortetraplex DNA ismoderately
reduced by removing asingle orpairs of basic
aminoacids triads
To assess more accurately the contribution of speciﬁc
basic amino acids clusters to the aﬃnity of MyoD for
tetraplex DNA, we determined the dissociation constants,
Kd, of complexes of the various MyoD deletion mutants
with G02 tetraplex integrin DNA. Typical Scatchard plots
of the association of constant amounts of full-length or
R3 MyoD with increasing amounts of 50 end-labeled G02
integrin DNA are presented in Figure 5. These analyses
indicated that in this particular experiment deletion of the
Figure 2. Deletion of MyoD residues 102–114 abolishes the binding of E-box but not of G02 tetraplex integrin DNA. Increasing amounts of
full-length MyoD or its 102–114 mutant were incubated under binding conditions with 50-
32P labeled double-stranded E-box or G02 integrin DNA.
Protein–DNA complexes were resolved from unbound DNA by non-denaturing polyacrylamide gel electrophoresis and the relative proportions of
protein-bound DNA were quantiﬁed by phosphor imaging analysis (see Materials and Methods section). Quantiﬁcation indicated that
the bimolecular G02 integrin DNA was in equilibrium with monomolecular G04 structure and that MyoD formed complexes solely with the G02
tetraplex (5). (A) Binding of E-box DNA by full-length and 102–114 MyoD. Left—autoradiogram of electrophoretically resolved protein–DNA
complexes. Right—plot of the quantiﬁed results. (B) Binding of G02 integrin DNA by full-length and 102–114 MyoD. Left—autoradiogram of
electrophoretically resolved protein–DNA complexes. Whereas full-length MyoD generated a single protein–DNA complex, the 102–114 mutant
protein formed two complexes. Right—plot of the quantiﬁed results. Percent G02 integrin DNA bound to 102–114 MyoD was the sum of the two
types of formed complexes.
Nucleic Acids Research, 2007, Vol. 35, No. 21 7091R3 triad of basic amino acids slightly elevated the aﬃnity
of MyoD for G02 integrin DNA. To obtain more complete
data, we conducted replicate similar determinations of the
Kd values of complexes of full-length and of MyoD
deletion mutant proteins with G02 integrin DNA. Results
of these measurements are compiled in Table 3. The
measured Kd of 5.8 1.8nM for complexes of full-length
MyoD with G02 integrin DNA was in the same range as
our previously published value of 2.3 1.6nM for these
complexes (5). The measured Kd value of 3.3 1.2nM of
complexes formed by the R3 MyoD mutant (Table 3)
indicated that presence of the R1 and R2 clusters in the
basic region without R3 was suﬃcient to maintain an
uncompromised aﬃnity of the protein for the tetraplex
DNA. Measurements of Kd values of complexes of mutant
proteins with deleted pairs of triads revealed that
each remaining single basic amino acids cluster suﬃced
for a relatively tight binding of G02 integrin DNA.
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Figure 4. Deletion of basic amino acid triads from the MyoD basic region abolishes binding of E-box but not of G02 tetraplex DNA. The 50-
32P
labeled double-stranded E-box or G02 tetraplex structures of integrin or sMtCK DNA were bound to diﬀerent amounts of full-length or the indicated
mutant MyoD proteins. Protein–DNA complexes were resolved from free DNA by non-denaturing gel electrophoresis as detailed in the legend to
Figure 2. (A) Autoradiograms of electrophoretically resolved protein–DNA complexes. Shown are results of DNA binding to 6 and 13pmol of each
examined MyoD protein. (B) Quantiﬁed results of the binding of increasing amounts of full-length and mutant MyoD proteins to G02 tetraplex
structures of integrin and sMtCK DNA.
Figure 3. An R111C mutation in MyoD abolishes its E-box-binding activity without aﬀecting the G02 tetraplex integrin DNA-binding capacity.
Full-length or R111C MyoD proteins were bound to 50-
32P labeled E-box or G02 integrin DNA and protein–DNA complexes were resolved by
non-denaturing gel electrophoresis and quantiﬁed as detailed in the legend to Figure 2. Presented are plots of percent E-box or G02 integrin DNA
bound as a function of the amounts of added full-length or mutant MyoD.
7092 Nucleic Acids Research, 2007, Vol. 35, No. 21However, not every cluster contributed equally to MyoD
and tetrahelical DNA complex formation. Relative to the
full-length protein, MyoD with R3 as its only existing triad
displayed only a 1.6-fold reduction in its aﬃnity for the
tetraplex DNA. Proteins that had R2 or R1 as their single
remaining cluster displayed modest relative diminution
of aﬃnity having, respectively, 2.0- and 4.6-fold higher
Kd values than full-length MyoD (Table 3).
DISCUSSION
The principal ﬁnding of this article is that overlapping but
distinct structural elements of MyoD homodimers are
employed in the binding of double-stranded E-box or
tetraplex structures of promoter sequences of muscle-
speciﬁc genes. Our results indicated that an intact MyoD
basic region is essential for the binding of E-box DNA.
The ability of MyoD to form a complex with E-box DNA
was completely lost by deleting the N-terminal two-thirds
of this region (Figure 2), in the absence of a single or
pairs of basic amino triads within this domain (Figure 4A)
or by introducing an R to C point mutation at residue
111 (Figure 3). By clear contrast, as illustrated in
Figures 2, 3 and 4, MyoD molecules that carried any
of these mutations maintained a capacity to associate with
G02 tetraplex structures of the integrin and sMtCK DNA
sequences. Notably, the double mutations R1R3 and
R2R3 decreased the binding of G02 sMtCK DNA to a
greater extent than the binding of G02 integrin DNA
(Figure 4B). This diﬀerence may be due to the diﬀerent
geometry of the two tetraplexes and their diﬀerent accom-
modation within the basic region of MyoD (vide infra).
Only deletion of all the three basic amino acids triads in
the MyoD basic region inactivated its tetraplex DNA-
binding capability. Data pointed to any one of the three
clusters R1,R 2 and R3 of basic amino acids in the basic
region of MyoD as an essential element in the binding of
tetraplex DNA structures. Thus, the presence of a single
cluster of three basic amino acids in a mutated basic
region was a necessary and suﬃcient condition for the
binding of the tetrahelical DNA structures (Figure 4
and Table 3).
To evaluate the signiﬁcance of the R1,R 2 and R3 basic
clusters, we surveyed the MyoD basic region by applying
the Web-based ConSurf 3.0 program which identiﬁes
evolutionarily conserved residues in functional domains of
proteins (29). Results of the analysis of a database
consisting of all MRF proteins as plotted in Figure 6A
indicated that except for residues 104 and 112 whose
conservation scores could not be signiﬁcantly determined,
other residues that comprised the R1,R 2 and R3 triads had
scores that ranged between 6 and 9, with 9 being the
highest achievable rank. Hence, it appeared that the triads
that were necessary for the binding of tetraplex DNA were
under strong evolutionary constraints. Figure 6B depicts
the crystal structure of the complex of the MyoD bHLH
domain with E-box DNA (30) with a color-coded
conservation score overlay. These data indicate that the
highly conserved R3 arginine residues 119 and 121 and
R2 arginine 111 maintain direct contact with the DNA.
By contrast, none of the residues that comprise the
R1 cluster are in contact with the E-box DNA (Figure 6B).
As no crystal structure is available yet of a complex
Figure 5. Representative Scatchard plots of the binding of G02 integrin DNA to full-length and to R3 mutant MyoD. DNA binding,
electrophoretic separation of protein–DNA complexes and their quantiﬁcation by phosphor imaging were performed as described in the legend to
Figure 2. Shown are autoradiograms (insets) and Scatchard plots of the quantiﬁed results. The dissociation constants, Kd, were calculated as detailed
under Materials and Methods section.
Table 3. MyoD mutants with a remaining single basic amino acid triad
maintain moderately reduced aﬃnity for G02 integrin DNA
Protein Remaining
motifs
Kd of protein-G02 integrin DNA
complex (nM) [N]
Full-length MyoD R1;R 2;R 3 5.8 1.8 [6]
R3 MyoD R1;R 2 3.3 1.2 [4]
R2R3 MyoD R1 26.4 6.9 [4]
R1R3 MyoD R2 11.8 4.1 [4]
102–114 MyoD R3 9.1 1.0 [3]
Dissociation constants, Kd, of complexes of 50-
32P labeled G02 integrin
DNA with the listed MyoD variant proteins were determined as
described under Materials and Methods section and in the legend to
Figure 5. Listed are average Kd values and SD for the indicated
numbers [N] of independent determinations.
Nucleic Acids Research, 2007, Vol. 35, No. 21 7093of the MyoD basic region with tetraplex DNA, we used
the molecular visualization applications PyMol (Delano
Scientiﬁc LLC) and DeepView Swiss-Pdb Viewer (Glaxo-
Smith and Swiss Institute of Bioinformatics) to super-
impose an image of G02 bimolecular tetraplex structure of
the telomeric sequence (TTAGGG)2 on the crystal
structure of the MyoD basic region. This modeling
suggested that to accommodate the tetraplex DNA,
which has wider dimensions than E-box, the dimeric
basic region should possess greater ﬂexibility. Thus, for
instance, it was observed that the loss of E-box-binding
capacity by the R111C mutant (Figure 2) was likely to be
due to interference by the substituting cysteine with
the positioning of the adjacent R110 residue relative to
the E-box. By contrast, the smaller dimensions of cysteine
relative to arginine made accommodation of the tetraplex
DNA possible. Interestingly, however, although each
of the basic triads was suﬃcient for the binding of tetra-
plex DNA, G02 integrin DNA was most tightly bound
by mutant MyoD that had as its sole cluster the R3 triad
which is most intimately associated with E-box
(Figure 6B). Accordingly, the MyoD mutant whose only
cluster was the more remote R1 triad displayed the
weakest association with the tetraplex DNA and the
midway positioned R2 cluster had intermediate aﬃnity for
the DNA (Table 3). These results raised the possibility
that despite their diﬀerent geometry, both E-box and
tetraplex DNA are similarly positioned most closely to the
R3 triad and most distantly to the R1 cluster.
Activation by MyoD of the transcription of muscle-
speciﬁc genes depends on two highly conserved amino
acids, alanine at position 114 and threonine at 115, termed
the myogenic code (31–33). These two residues together
with a lysine in the junction of the ﬁrst helix of MyoD
are suﬃcient to induce myogenesis (32,34). An A114N
mutation was reported to decrease by 3-fold the binding of
MyoD homodimers to E-box and to completely abolish
transcription activation by MyoD/E47 heterodimers (35).
Our results showed that homodimers of the 102–114
mutant MyoD protein failed to bind E-box whereas their
ability to bind G02 integrin DNA was minimally aﬀected
(Figure 2). This minor eﬀect of the absence of A114 on
complex formation with tetraplex DNA contrasted the
contribution of this residue to the binding of MyoD
homodimers to E-box and its essential role in transcrip-
tion activation and underscored the diﬀerent interaction
of the two DNA types with MyoD.
We recently proposed that tetrahelical structures in
regulatory sequences of muscle-speciﬁc genes may trap
MyoD homodimers to limit their competition with
MyoD/E2A heterodimers on E-box occupancy (5). This
idea gains support both by the preferential binding
of MyoD homodimers to tetraplex DNA over E-box (5)
as well as by the presently reported permissive versus
stringent protein structure requirements for their associa-
tion with tetrahelical DNA and E-box, respectively.
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